ALIGOS THERAPEUTICS INC (ALGS) Stock Cash Flow
NASDAQ:ALGS - US01626L2043 - Common Stock
11.34 USD
+0.6 (+5.59%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -74.18M | -131.21M | -87.68M | -96.05M | -128.33M | |||
| Depreciation Amortization | 942.00K | 1.03M | 1.56M | 2.31M | 3.02M | |||
| Change In Working Capital | -6.48M | -4.96M | -9.53M | -1.55M | -4.65M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | N/A | |||
| Other non cash items | 4.80M | 54.40M | 16.65M | 15.90M | 14.30M | |||
| OPERATING CASH FLOW | -74.92M | -80.74M | -79.00M | -79.39M | -115.66M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -206.00K | -130.00K | -19.00K | -940.00K | -890.00K | |||
| Other Investing Activity | -52.91M | -18.15M | 45.00M | -25.35M | 3.91M | |||
| INVESTING CASH FLOW | -53.12M | -18.28M | 44.98M | -26.29M | 3.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -83.00K | -96.00K | -60.00K | -80.00K | |||
| Stock Issued/Repurchased | 101.71M | 438.00K | 88.42M | 230.00K | 79.63M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | -880.00K | |||
| FINANCING CASH FLOW | 101.66M | 355.00K | 88.33M | 160.00K | 78.68M | |||
| CHANGE IN CASH | -26.38M | -98.67M | 54.31M | -105.52M | -33.96M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -74.92M | -80.74M | -79.00M | -79.39M | -115.66M | |||
| Capital Expenditure | -206.00K | -130.00K | -19.00K | -940.00K | -890.00K | |||
| FREE CASH FLOW | -75.12M | -80.87M | -79.02M | -80.33M | -116.55M | |||
All data in USD